Dr.Yi Shi joined Lilly Asian Ventures in 2007 as the Managing Director based in Shanghai, China. Prior to the current assignment, he worked in various roles with increasing responsibility over six years at Eli Lilly and Company. His experience includes leading the development of a comprehensive investment strategy for China as well as negotiating multiple biotechnology and pre-clinical deals world-wide. Dr.Shi was also instrumental in the founding of InnoCentive, Inc., a Lilly Ventures portfolio company, where he managed scientific operations as well as its expansion into China. Before joining Lilly, Dr.Shi was the Chief Sales and Marketing Officer of NetBig.com, an internet start-up, where he successfully grew the company to become the number one education and technology portal in China. He began his career as a Management Consultant with Ernst & Young in the Life Science Practice Group and specialized in Sales and Marketing strategy. Dr.Shi received a Ph.D. in Biochemistry and a Master degree in Business Administration, both from Duke University. He also earned a Bachelor degree in Biology from the University of Science and Technology of China.